BMS-938790, a PEG-adnectin targeting hIL-23, for treatment of inflammatory diseases March 12, 2015 No Comments
Specific inhibition of NLRP3 shows potential for the treatment of inflammatory diseases Feb. 20, 2015 No Comments
Leading BioSciences cleared to begin phase II study of LB-1148 in septic shock Feb. 5, 2015 No Comments
Previously identified RIP1 kinase inhibitor potentially useful for necroptosis Jan. 24, 2014 No Comments
RSS